leg pain semaglutide Peripheral artery disease: An update Ozempic: Weight Loss Drugs May

10.1056/NEJMoa1603827 216

Wegovy is approved by the FDA for weight loss in order to treat obesity

This was attributed to increased expressions of PD-L1 by glycolysis, which confirms the importance of glycolytic activities in immunotherapeutic efficacy (105)

"If changes in taste are linked to greater appetite control and weight loss, this could help clinicians better select therapies, provide more tailored dietary advice and improve long-term treatment outcomes for patients." To find out more, Professor Moser and colleagues from the Medical University of Vienna surveyed hundreds of individuals with overweight and obesity who were taking Ozempic, Wegovy or Mounjaro for weight loss about their sense of taste and appetite

275 PallML